Anemia in conventional hemodialysis: Finding the optimal treatment balance
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anemia in conventional hemodialysis: Finding the optimal treatment balance
Authors
Keywords
-
Journal
SEMINARS IN DIALYSIS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-06-18
DOI
10.1111/sdi.12719
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety of Intravenous Iron in Dialysis
- (2018) Ingrid Hougen et al. Clinical Journal of the American Society of Nephrology
- Association between post-dialysis hemoglobin level and the survival of vascular access
- (2018) Hiroki Nishiwaki et al. Journal of Vascular Access
- Prolyl hydroxylase domain inhibitors as a novel therapeutic approach against anemia in chronic kidney disease
- (2017) Mai Sugahara et al. KIDNEY INTERNATIONAL
- Efficacy and safety of sucroferric oxyhydroxide compared with sevelamer hydrochloride in Japanese haemodialysis patients with hyperphosphataemia: A randomized, open-label, multicentre, 12-week phase III study
- (2017) Fumihiko Koiwa et al. NEPHROLOGY
- Safety of intravenous ferric carboxymaltose versus oral iron in patients with nondialysis-dependent CKD: an analysis of the 1-year FIND-CKD trial
- (2017) Simon D. Roger et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Human pluripotent stem cell–derived erythropoietin-producing cells ameliorate renal anemia in mice
- (2017) Hirofumi Hitomi et al. Science Translational Medicine
- Discovery of JTZ-951: A HIF Prolyl Hydroxylase Inhibitor for the Treatment of Renal Anemia
- (2017) Yosuke Ogoshi et al. ACS Medicinal Chemistry Letters
- New Treatment Approaches for the Anemia of CKD
- (2016) Mario Bonomini et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Effects of Daprodustat, a Novel Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor on Anemia Management in Japanese Hemodialysis Subjects
- (2016) Tadao Akizawa et al. AMERICAN JOURNAL OF NEPHROLOGY
- Safety, pharmacokinetics and pharmacodynamics of the anti-hepcidin Spiegelmer lexaptepid pegol in healthy subjects
- (2016) M Boyce et al. BRITISH JOURNAL OF PHARMACOLOGY
- Dose–response efficacy and safety of PA21 in Japanese hemodialysis patients with hyperphosphatemia: a randomized, placebo-controlled, double-blind, Phase II study
- (2016) Fumihiko Koiwa et al. Clinical and Experimental Nephrology
- International Comparisons to Assess Effects of Payment and Regulatory Changes in the United States on Anemia Practice in Patients on Hemodialysis: The Dialysis Outcomes and Practice Patterns Study
- (2015) D. S. Fuller et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Four-Week Studies of Oral Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor GSK1278863 for Treatment of Anemia
- (2015) L. Holdstock et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Roxadustat (FG-4592): Correction of Anemia in Incident Dialysis Patients
- (2015) A. Besarab et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- New data on the safety of IV iron—but why the discrepancy with FIND-CKD?
- (2015) Iain C. Macdougall et al. KIDNEY INTERNATIONAL
- A randomized trial of intravenous and oral iron in chronic kidney disease
- (2015) Rajiv Agarwal et al. KIDNEY INTERNATIONAL
- Data from the Dialysis Outcomes and Practice Patterns Study validate an association between high intravenous iron doses and mortality
- (2015) George R. Bailie et al. KIDNEY INTERNATIONAL
- Effects of vitamin E-coated dialysis membranes on anemia, nutrition and dyslipidemia status in hemodialysis patients: a meta-analysis
- (2015) Jing Huang et al. RENAL FAILURE
- The Different Association between Serum Ferritin and Mortality in Hemodialysis and Peritoneal Dialysis Patients Using Japanese Nationwide Dialysis Registry
- (2015) Yukio Maruyama et al. PLoS One
- Effect of the antihepcidin Spiegelmer lexaptepid on inflammation-induced decrease in serum iron in humans
- (2014) L. T. van Eijk et al. BLOOD
- Ferric Citrate Hydrate for the Treatment of Hyperphosphatemia in Nondialysis-Dependent CKD
- (2014) K. Yokoyama et al. Clinical Journal of the American Society of Nephrology
- New treatment approaches in chronic kidney disease-associated anaemia
- (2014) Lucia Del Vecchio et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Considerations and Challenges in Defining Optimal Iron Utilization in Hemodialysis
- (2014) D. M. Charytan et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Age and anemia management: relationship of hemoglobin levels with mortality might differ between elderly and nonelderly hemodialysis patients
- (2014) Norio Hanafusa et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Mimicking Hypoxia to Treat Anemia: HIF-Stabilizer BAY 85-3934 (Molidustat) Stimulates Erythropoietin Production without Hypertensive Effects
- (2014) Ingo Flamme et al. PLoS One
- Low Hemoglobin Levels and Hypo-Responsiveness to Erythropoiesis-Stimulating Agent Associated With Poor Survival in Incident Japanese Hemodialysis Patients
- (2014) Tadao Akizawa et al. THERAPEUTIC APHERESIS AND DIALYSIS
- KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for Anemia in CKD
- (2013) Alan S. Kliger et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Infection Risk with Bolus versus Maintenance Iron Supplementation in Hemodialysis Patients
- (2013) M. A. Brookhart et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Variation in intravenous iron use internationally and over time: the Dialysis Outcomes and Practice Patterns Study (DOPPS)
- (2013) G. R. Bailie et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Kidney Disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement
- (2013) Francesco Locatelli et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- A randomized trial of JTT-751 versus sevelamer hydrochloride in patients on hemodialysis
- (2013) K. Yokoyama et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- The FIND-CKD study—a randomized controlled trial of intravenous iron versus oral iron in non-dialysis chronic kidney disease patients: background and rationale
- (2013) Iain C. Macdougall et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Dose of Erythropoiesis-Stimulating Agents and Adverse Outcomes in CKD: A Metaregression Analysis
- (2012) Ioannis Koulouridis et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Erythropoiesis-Stimulating Agent Responsiveness and Mortality in Hemodialysis Patients: Results from a Cohort Study From the Dialysis Registry in Japan
- (2011) Shingo Fukuma et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Hepcidin: another culprit for complications in patients with chronic kidney disease?
- (2011) T. Nakanishi et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Systematic review of the impact of erythropoiesis-stimulating agents on fatigue in dialysis patients
- (2011) K. L. Johansen et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Reduction of Serum Hepcidin by Hemodialysis in Pediatric and Adult Patients
- (2010) J. Zaritsky et al. Clinical Journal of the American Society of Nephrology
- Naturally Occurring Higher Hemoglobin Concentration Does Not Increase Mortality among Hemodialysis Patients
- (2010) D. A. Goodkin et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- International trends in erythropoietin use and hemoglobin levels in hemodialysis patients
- (2010) Philip A. McFarlane et al. KIDNEY INTERNATIONAL
- Changes in anemia management and hemoglobin levels following revision of a bundling policy to incorporate recombinant human erythropoietin
- (2010) Takeshi Hasegawa et al. KIDNEY INTERNATIONAL
- Erythropoietic Response and Outcomes in Kidney Disease and Type 2 Diabetes
- (2010) Scott D. Solomon et al. NEW ENGLAND JOURNAL OF MEDICINE
- 2008 Japanese Society for Dialysis Therapy: Guidelines for Renal Anemia in Chronic Kidney Disease
- (2010) Yoshiharu Tsubakihara et al. THERAPEUTIC APHERESIS AND DIALYSIS
- Hepcidin--A Potential Novel Biomarker for Iron Status in Chronic Kidney Disease
- (2009) J. Zaritsky et al. Clinical Journal of the American Society of Nephrology
- A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
- (2009) Marc A. Pfeffer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Greater Epoetin alfa Responsiveness Is Associated With Improved Survival in Hemodialysis Patients
- (2008) R. D. Kilpatrick et al. Clinical Journal of the American Society of Nephrology
- The Effect of Altitude on Dosing and Response to Erythropoietin in ESRD
- (2008) M. A. Brookhart et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Japanese haemodialysis anaemia management practices and outcomes (1999-2006): results from the DOPPS
- (2008) T. Akizawa et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now